Bacil Pharma Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported revenue was INR 0.576 million compared to INR 0.739 million a year ago. Net loss was INR 38.6 million compared to INR 2.39 million a year ago. Basic loss per share from continuing operations was INR 6.55 compared to INR 0.41 a year ago. Diluted loss per share from continuing operations was INR 6.55 compared to INR 0.41 a year ago.